People · Operator

Anya Hayden

Named in public records as an officer, director or promoter · active 2017–2017 · Biotech / Pharma

1
Companies
1
Filings
$13.6M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Pharmaca Integrative Pharmacy IncBiotech / PharmaSeries A$13.6M$234.5M2017
Operator network

Anya Hayden at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Corey Mulloy · 5 companies · 1 sharedCorey MulloyRichard Willis · 5 companies · 1 sharedRichard WillisWilliam Rosenzweig · 5 companies · 1 sharedWilliam RosenzweigGreg Scott · 3 companies · 1 sharedGreg ScottJoel D. Liffmann · 3 companies · 1 sharedJoel D. LiffmannThomas Stemberg · 3 companies · 1 sharedThomas StembergAlan Kessock · 2 companies · 1 sharedAlan KessockDavid Maher · 2 companies · 1 sharedDavid MaherMartin Hanaka · 2 companies · 1 sharedMartin HanakaPeter Cornetta · 2 companies · 1 sharedPeter CornettaBarry Perzow · 1 companies · 1 sharedBarry PerzowGregory D. Scott · 1 companies · 1 sharedGregory D. ScottJanet Mathews · 1 companies · 1 sharedJanet MathewsJoel Liffmann · 1 companies · 1 sharedJoel LiffmannMark Panzer · 1 companies · 1 sharedMark PanzerMichael Kruteck · 1 companies · 1 sharedMichael KruteckPharmaca Integrative Pharmacy Inc · $13.6M raisedPharmaca Integrative …Anya HaydenAH
Anya Hayden Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Anya Hayden on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Corey Mulloy15
Richard Willis15
William Rosenzweig15
Greg Scott13
Thomas Stemberg13
Joel D. Liffmann13
Alan Kessock12
Martin Hanaka12
David Maher12
Peter Cornetta12
Joel Liffmann11
Michael Kruteck11
Barry Perzow11
Janet Mathews11
Gregory D. Scott11
Mark Panzer11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.